Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Providers & Payors

Boston Scientific’s Intracept: Winning Reimbursement in a Tough Indication

  • 3 days ago
  • Wendy Diller

Six years after launching, Boston Scientific’s pioneering Intracept procedure for vertebrogenic chronic low back pain has revenues of roughly $200 million and reimbursement coverage surpassing 200 million lives, including high-profile wins such as HCSC and TRICARE, thanks to a careful, nuanced strategy. Still, major holdouts like UnitedHealthcare and Aetna illustrate the complexity of today’s reimbursement landscape.

Subscribe

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe
View More
View More
Subscribe

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Subscribe
View More
View More
View More

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More